Le Lézard
Classified in: Health
Subject: SVY

Osteoarthritis Pain Market in Europe to 2026: Analysis on Epidemiology, Patient Flow, Prevalence and Diagnosed & Treated Patients


DUBLIN, July 13, 2018 /PRNewswire/ --

The "Europe Osteoarthritis Pain Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The research provides insights into Osteoarthritis Pain epidemiology, Osteoarthritis Pain diagnosed patients, and Osteoarthritis Pain treatment rate for EU5 countries. The research measures key indicators including prevalence of Osteoarthritis Pain derived from epidemiological analysis, patients diagnosed with Osteoarthritis Pain, and patients treated with a drug therapy.

The research study helps executives estimate Osteoarthritis Pain market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Osteoarthritis Pain prevalence, Osteoarthritis Pain diagnosis rate, and Osteoarthritis Pain treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Topics Covered

1. Osteoarthritis Pain: Disease Definition



2. Osteoarthritis Pain Patient Flow in Europe


2A. Osteoarthritis Pain Prevalence in Europe


2B. Osteoarthritis Pain Diagnosed Patients in Europe


2C. Osteoarthritis Pain Treated Patients in Europe



3. Osteoarthritis Pain Patient Flow in Germany


3A. Osteoarthritis Pain Prevalence in Germany


3B. Osteoarthritis Pain Diagnosed Patients in Germany


3C. Osteoarthritis Pain Treated Patients in Germany


4. Osteoarthritis Pain Patient Flow in France


4A. Osteoarthritis Pain Prevalence in France


4B. Osteoarthritis Pain Diagnosed Patients in France


4C. Osteoarthritis Pain Treated Patients in France



5. Osteoarthritis Pain Patient Flow in Spain


5A. Osteoarthritis Pain Prevalence in Spain


5B. Osteoarthritis Pain Diagnosed Patients in Spain


5C. Osteoarthritis Pain Treated Patients in Spain



6. Osteoarthritis Pain Patient Flow in Italy


6A. Osteoarthritis Pain Prevalence in Italy


6B. Osteoarthritis Pain Diagnosed Patients in Italy


6C. Osteoarthritis Pain Treated Patients in Italy



7. Osteoarthritis Pain Patient Flow in UK


7A. Osteoarthritis Pain Prevalence in UK


7B. Osteoarthritis Pain Diagnosed Patients in UK


7C. Osteoarthritis Pain Treated Patients in UK



8. Research Methodology



For more information about this report visit

https://www.researchandmarkets.com/research/tzb87k/osteoarthritis?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:


Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 08:35
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company...

at 08:34
Hire Velocity, a leading provider of recruitment process outsourcing (RPO) and professional search solutions, announced the launch of Hire Health, a healthcare-focused human capital solutions firm. The launch of Hire Health reinforces Hire Velocity's...

at 08:31
RTI International, a nonprofit research institute, and Nested Knowledge, a platform for AI-driven evidence synthesis, systematic literature review and meta-analysis, formally announce a strategic collaboration between the two organizations. The...

at 08:30
According to a new report published by Dialogue Health Technologies Inc., Canada's leading health and wellness virtual care platform, Canadians' overall well-being is at a low point as they struggle with lifestyle challenges around sleep and physical...

at 08:30
Selecting appropriate sites is one of the most crucial determinants of study success, yet efficient clinical trial site selection continues to be a prominent industry-wide...

at 08:30
In the news release, Nanalysis Announces Full Year 2023 Conference Call, issued 11-Apr-2024 by Nanalysis Scientific Corp. over CNW, we are advised by the company that the Hosting Call and European Q&A Session date mentioned should read "Monday, April...



News published on and distributed by: